Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,466,459
in 2 filings

Net −$1,466,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-02-19 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +7,000 $26.49 $185K 302,552
2021-02-19 BIENAIME JEAN JACQUES Chief Executive Officer Sale −7,000 $83.58 $585K 295,552
2021-02-19 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −7,000 92,513
2021-02-18 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +7,000 $26.49 $185K 302,552
2021-02-18 BIENAIME JEAN JACQUES Chief Executive Officer Sale −7,000 $85.08 $596K 295,552
2021-02-18 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −7,000 99,513
2021-02-17 Ho Maykin Director Grant or award +2,350 2,350
2021-02-17 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +8,000 $26.49 $212K 303,552
2021-02-17 BIENAIME JEAN JACQUES Chief Executive Officer Sale −8,000 $84.54 $676K 295,552
2021-02-17 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −8,000 106,513
2021-02-16 LAWLIS V BRYAN Director Exercise or conversion +7,500 $26.49 $199K 26,350
2021-02-16 LAWLIS V BRYAN Director Sale −7,500 $87.41 $656K 18,850
2021-02-16 LAWLIS V BRYAN Director Exercise or conversion · Stock Option (Right to buy Common Stock) −7,500 7,500
2021-02-03 Mueller Brian EVP, Chief Financial Officer Shares withheld for taxes −1,071 $82.82 $89K 28,673
2021-01-29 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +8,334 $26.49 $221K 303,886
2021-01-29 BIENAIME JEAN JACQUES Chief Executive Officer Sale −8,334 $82.67 $689K 295,552
2021-01-29 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −8,334 114,513
2021-01-28 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +8,333 $26.49 $221K 303,885
2021-01-28 BIENAIME JEAN JACQUES Chief Executive Officer Sale −8,333 $82.91 $691K 295,552
2021-01-28 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −8,333 122,847

Page 33 of 36 · 707 trades